Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma
出版年份 2023 全文链接
标题
Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma
作者
关键词
-
出版物
LUNG CANCER
Volume 185, Issue -, Pages 107360
出版商
Elsevier BV
发表日期
2023-09-07
DOI
10.1016/j.lungcan.2023.107360
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- TROP2 expression and SN38 antitumor activity in malignant pleural mesothelioma cells provide a rationale for antibody-drug conjugate therapy
- (2023) Luca Hegedüs et al. LUNG CANCER
- Novel Insights Into Mesothelioma Therapy: Emerging Avenues and Future Prospects
- (2022) Lukasz Kuryk et al. Frontiers in Oncology
- First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
- (2021) Paul Baas et al. LANCET
- MUC1: Structure, Function, and Clinic Application in Epithelial Cancers
- (2021) Wenqing Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MUC1 is an oncoprotein with a significant role in apoptosis (Review)
- (2021) Katarzyna Supruniuk et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Telomerase Reverse Transcriptase Promoter Mutations Identify a Genomically Defined and Highly Aggressive Human Pleural Mesothelioma Subgroup
- (2020) Christine Pirker et al. CLINICAL CANCER RESEARCH
- Serum KL‐6 concentrations as a novel biomarker of severe COVID19
- (2020) Miriana d'Alessandro et al. JOURNAL OF MEDICAL VIROLOGY
- HDAC inhibition synergizes with ALK inhibitors to overcome resistance in a novel ALK mutated lung adenocarcinoma model
- (2020) Paul Stockhammer et al. LUNG CANCER
- Multicellular contractility contributes to the emergence of mesothelioma nodules
- (2020) Julia Tarnoki-Zach et al. Scientific Reports
- Intrapleural immunotherapy: An update on emerging treatment strategies for pleural malignancy
- (2019) Vivek Murthy et al. Clinical Respiratory Journal
- Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma
- (2019) Paul Stockhammer et al. LUNG CANCER
- MUC1/KL-6 expression confers an aggressive phenotype upon myeloma cells
- (2018) Shinya Endo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Changes in serum KL-6 levels are associated with the development of chronic lung allograft dysfunction in lung transplant recipients
- (2018) V. Bessa et al. TRANSPLANT IMMUNOLOGY
- Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression
- (2017) Sho Sato et al. Oncology Letters
- Mesothelin Immunotherapy for Cancer: Ready for Prime Time?
- (2016) Raffit Hassan et al. JOURNAL OF CLINICAL ONCOLOGY
- Malignant pleural fluid from mesothelioma has potent biological activities
- (2016) Hui Min Cheah et al. RESPIROLOGY
- The established and future biomarkers of malignant pleural mesothelioma
- (2015) V. Panou et al. CANCER TREATMENT REVIEWS
- Targeted Proteomics Pipeline Reveals Potential Biomarkers for the Diagnosis of Metastatic Lung Cancer in Pleural Effusion
- (2014) Chi-De Chen et al. JOURNAL OF PROTEOME RESEARCH
- Diagnostic value of MUC1 and EpCAM mRNA as tumor markers in differentiating benign from malignant pleural effusion
- (2014) W. Sun et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- MUC1: a multifaceted oncoprotein with a key role in cancer progression
- (2014) Sritama Nath et al. TRENDS IN MOLECULAR MEDICINE
- Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer
- (2014) Huan-Li Xu WORLD JOURNAL OF GASTROENTEROLOGY
- Diagnostic Usefulness of MUC1 and MUC4 for Distinguishing between Metastatic Adenocarcinoma Cells and Reactive Mesothelial Cells in Effusion Cell Blocks
- (2013) Jin Seong Cho et al. ACTA CYTOLOGICA
- Enhancement of in vitro cell motility and invasiveness of human malignant pleural mesothelioma cells through the HIF-1α-MUC1 pathway
- (2013) Houman Goudarzi et al. CANCER LETTERS
- Mucins in pancreatic cancer and its microenvironment
- (2013) Sukhwinder Kaur et al. Nature Reviews Gastroenterology & Hepatology
- Malignant Pleural Effusion
- (2012) Georgios T. Stathopoulos et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Recognition of pleural mesothelioma by mucin-1(950-958)/human leukocyte antigen A*0201-specific CD8+ T-cells
- (2011) D. Roulois et al. EUROPEAN RESPIRATORY JOURNAL
- Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer
- (2011) Sonosuke Tanaka et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of KL-6/MUC1 in pancreatic ductal carcinoma and its potential relationship with β-catenin in tumor progression
- (2011) Huanli Xu et al. LIFE SCIENCES
- The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
- (2009) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
- (2009) A. Scherpereel et al. EUROPEAN RESPIRATORY JOURNAL
- Overexpression and altered glycosylation of MUC1 in malignant mesothelioma
- (2008) J Creaney et al. BRITISH JOURNAL OF CANCER
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started